How many insider declarations has Bjork Elisabeth filed?

Bjork Elisabeth has filed 3 public insider declarations with SEC (Form 4).

What is Bjork Elisabeth's role?

Bjork Elisabeth's reported role is not specified by the regulator across the filings.

Which companies does Bjork Elisabeth report trades for?

Bjork Elisabeth reports trades for 2 companies, including Pharvaris N.V..

What is Bjork Elisabeth's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 252k€.

← Executives ★ Sign in to follow

BE

Bjork Elisabeth

OFFICER

·SEC (Form 4)

Pharvaris N.V.Rocket Pharmaceuticals, INC.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€252,178

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the full record of transactions filed by Bjork Elisabeth. Director active across 2 companies, notably Pharvaris N.V.. Cumulatively, 3 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €252k. Activity tracked since 18 June 2025. The latest transaction was filed on 20 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Bjork Elisabeth

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Pharvaris N.V. (US)Rocket Pharmaceuticals, INC. (US)

申报3 总计

◇

Bjork Elisabeth

Director高管2026年5月20日Pharvaris N.V.

US$80,50019SEC ↗

10,000 股@ US$8.050.0033% mcap21.5% 占其流量Common StockSEC:0001193125-26-236432:0

▼

Bjork Elisabeth

Director高管2026年5月20日Pharvaris N.V.

US$293,16639SEC ↗

10,000 股@ US$29.31660.012% mcap78.5% 占其流量Common StockSEC:0001193125-26-236432:1

◆

Bjork Elisabeth

Director高管2025年6月18日Rocket Pharmaceuticals, INC.

0SEC ↗

30,000 股0Common StockSEC:0001140361-25-026405:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

BE

Bjork Elisabeth

OFFICER

·SEC (Form 4)

Pharvaris N.V.Rocket Pharmaceuticals, INC.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€252,178

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the full record of transactions filed by Bjork Elisabeth. Director active across 2 companies, notably Pharvaris N.V.. Cumulatively, 3 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €252k. Activity tracked since 18 June 2025. The latest transaction was filed on 20 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.